P3 Health Partners enters Nebraska Medicare Advantage agreement with large nonprofit health insurer

P3 Health Partners Inc.

P3 will provide clinical, operational, and data-driven support to primary care providers in client’s Nebraska Medicare Advantage network.
Management services fees for performance years 2026 and 2027; global risk arrangement for 2028 and beyond.
Master Services Agreement initial term through Dec 31, 2030, with automatic one-year renewal unless 180-day notice given.
Client may terminate SOW upon 90-day notice if P3 fails to meet agreed performance metrics for 2026 or if key persons depart.
If client opts not to pursue CMS Medicare Advantage bid for 2027-2028, SOW terminates with break-up fee covering actual costs plus direct termination costs, capped at an agreed amount.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

P3 Health Partners Inc. entered into Statement of Work with a large nonprofit health insurance provider in the state of Nebraska (effective 2026-03-19).

Action: entry
Counterparty: a large nonprofit health insurance provider in the state of Nebraska
Effective: 2026-03-19

Exact text from the filing

Effective as of March 19, 2026, P3 Health Partners, LLC (the “Company”) entered into a Statement of Work (the “SOW”) with a large nonprofit health insurance provider in the state of Nebraska (the “Client”), which incorporates the terms of a Master Services Agreement between the parties (the (the “MSA,” and together with the SOW, the “Agreements”).

View on SEC.gov

299 material agreements filed in the last 30 days. Browse all material agreements →

P3 Health Partners Inc. filing history →

Source: SEC EDGAR

accession 0001832511-26-000006

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.